Academic literature on the topic 'SET-2 cell lines'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'SET-2 cell lines.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "SET-2 cell lines"
Santamaria, P., T. Utsugi, B. J. Park, N. Averill, S. Kawazu, and J. W. Yoon. "Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences." Journal of Immunology 154, no. 5 (March 1, 1995): 2494–503. http://dx.doi.org/10.4049/jimmunol.154.5.2494.
Full textQuentmeier, Hilmar, Claudia Pommerenke, and Hans G. Drexler. "Epigenetic Modifier Mutations in the LL-100 Panel." Blood 132, Supplement 1 (November 29, 2018): 5271. http://dx.doi.org/10.1182/blood-2018-99-110060.
Full textMoudgil, Tarsem, Bernard Fox, and Hong-Ming Hu. "85 Detection of human angiotensin-converting enzyme 2 receptor (hACE2R) on human cancer cell lines." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A93. http://dx.doi.org/10.1136/jitc-2021-sitc2021.085.
Full textNagai, T., H. Harigae, H. Ishihara, H. Motohashi, N. Minegishi, S. Tsuchiya, N. Hayashi, L. Gu, B. Andres, and JD Engel. "Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines." Blood 84, no. 4 (August 15, 1994): 1074–84. http://dx.doi.org/10.1182/blood.v84.4.1074.1074.
Full textNagai, T., H. Harigae, H. Ishihara, H. Motohashi, N. Minegishi, S. Tsuchiya, N. Hayashi, L. Gu, B. Andres, and JD Engel. "Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines." Blood 84, no. 4 (August 15, 1994): 1074–84. http://dx.doi.org/10.1182/blood.v84.4.1074.bloodjournal8441074.
Full textResar, Linda, Donna Marie Williams, Lingling Xian, Wenyan Lu, Briyana Chisholm, Li Luo, Zhizhuang Joe Zhao, Ophelia Rogers, Jerry L. Spivak, and Alison R. Moliterno. "High Mobility Group A1 Chromatin Remodeling Proteins Amplify Inflammatory Networks to Drive Leukemic Transformation in Chronic Myeloproliferative Neoplasia in Humans and JAK2V617F Transgenic Mouse Models." Blood 132, Supplement 1 (November 29, 2018): 102. http://dx.doi.org/10.1182/blood-2018-99-119549.
Full textLindhout, E., A. Lakeman, M. L. Mevissen, and C. de Groot. "Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines." Journal of Experimental Medicine 179, no. 4 (April 1, 1994): 1173–84. http://dx.doi.org/10.1084/jem.179.4.1173.
Full textTroeger, Anja, Pascal-David Johann, Mumine Senturk, Michael D. Milsom, and David A. Williams. "Intact Rac Signaling Is Important for Leukemia Cell Survival." Blood 116, no. 21 (November 19, 2010): 2885. http://dx.doi.org/10.1182/blood.v116.21.2885.2885.
Full textVerheul, C., T. V. Kers, A. Van Der Ploeg, M. Van Der Kaaij, M. Aghababazadeh, M. De Wit, Y. Hoogstrate, et al. "P11.47 Generation, characterisation and drug screening of patient-derivedIDH1-mutated glioma cell lines." Neuro-Oncology 21, Supplement_3 (August 2019): iii54. http://dx.doi.org/10.1093/neuonc/noz126.193.
Full textGozgit, Joseph M., Geraldine A. Bebernitz, Pankaj Patil, Minwei Ye, Jiaquan Wu, Stephanos Ioannidis, Audrey Davies, Tao Wang, Dennis Huszar, and Michael Zinda. "Effects of a Novel, Selective Jak2 Inhibitor, AZ60, on STAT5 Signaling and Cellular Growth in Jak2 V617F Cell Lines." Blood 110, no. 11 (November 16, 2007): 3549. http://dx.doi.org/10.1182/blood.v110.11.3549.3549.
Full textDissertations / Theses on the topic "SET-2 cell lines"
Marino, Luigi. "Ruolo del Ruxolitinib nel cross-talk tra cellule staminali mesenchimali e microambiente midollare nella mielofibrosi." Doctoral thesis, Universita degli studi di Salerno, 2019. http://elea.unisa.it:8080/xmlui/handle/10556/4243.
Full textIntroduction; Mesenchymal stem cells (Mesenchymal Stem Cells, MSC) are one of the most studied and well-characterized adult stem cell populations. They are excellent candidates in regenerative medicine, mainly because of their immunomodulatory properties and their emerging role in intercellular communication. MSCs as cellular components of bone marrow hematopoietic niche play a fundamental role in maintaining the physiological balance of the niche and in promoting and regulating hematopoietic stem cell (HSCs) functions, such as proliferation and "homing" to the bone marrow. - Methods: In this work, we focused on the possible internalization and release of Ruxolitinib (a JAK1/2 inhibitor by NOVARTIS Pharma) by MSC. In details, primary human MSC were isolated from bone marrow (BMMSC) of five patients diagnosed with Idiopathic Myelofibrosis or Polycythemia Vera. Diagnosis was confirmed by histopathology and molecular biology for the detection of mutations in Janus Kinase 2 receptor encoding gene, specifically for JAK2 V617F mutation. Subsequently, we evaluated the in vitro anti-proliferative effect of culture medium conditioned with Ruxolitinib on immortalized JAK2+ CD34+ SET-2 cells. Finally, a co-culture system of BMMSC and SET-2 cells treated or not with Ruxolitinib in different ratios (1:20, 1: 100 and 1: 1000) was used for estimating the relative anti-proliferative action on SET-2 cell line. - Results: Our preliminary results showed that MSCs could uptake and release Ruxolitinib in culture medium, and conditioned culture medium had more anti-proliferative effects on SET-2 cells compared to the drug alone added to the medium. In an in vitro co-culture system, the proliferation of SET-2 cells decreased by increasing MSC ratio treated with Ruxolitinib / SET-2, and BMMSC treated with Ruxolitinib had a greater anti-proliferative action on SET-2 cells compared to untreated BMMSCs. - Conclusions: Mesenchymal bone marrow stem cells could uptake and release Ruxolitinib that might increase the anti-proliferative effect of the drug on SET-2 cell line carrying the JAK2 V617F mutation. These mechanisms may contribute to amplify over time the pharmacological effects of Ruxolitinib in the bone marrow niche of Idiopathic Myelofibrosis and Polycythemia Vera patients. [edited by Author]
XXXI ciclo
Book chapters on the topic "SET-2 cell lines"
Taber, Douglass F. "The Reisman Synthesis of (+)-Salvileucalin B." In Organic Synthesis. Oxford University Press, 2015. http://dx.doi.org/10.1093/oso/9780190200794.003.0084.
Full textTaber, Douglass F. "The Shair Synthesis of Cephalostatin 1." In Organic Synthesis. Oxford University Press, 2013. http://dx.doi.org/10.1093/oso/9780199965724.003.0093.
Full textTaber, Douglass F. "The Nakada Synthesis of (+)-Ophiobolin A." In Organic Synthesis. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190646165.003.0084.
Full textMclntyre, Donald B. "An Executable Notation, With Illustrations From Elementary Crystallography." In Computers in Geology - 25 Years of Progress. Oxford University Press, 1994. http://dx.doi.org/10.1093/oso/9780195085938.003.0024.
Full textCook, Matthew. "Still Life Theory." In New Constructions in Cellular Automata. Oxford University Press, 2003. http://dx.doi.org/10.1093/oso/9780195137170.003.0008.
Full textWong, Agnes. "Ocular Motor Disorders Caused by Lesions in the Brainstem." In Eye Movement Disorders. Oxford University Press, 2008. http://dx.doi.org/10.1093/oso/9780195324266.003.0017.
Full text"designation will be used for the 12E7 antigen. CD99 was first detected by 12E7, a monoclonal antibody made in response to a T-cell line, and was initially thought to be a ‘thymus-leukaemia’ marker antigen [41]. Many similar antibodies were made which reacted with different epitopes of the same molecule [see 42]. Independently, CD99 was identified as E2, a T-cell adhesion molecule, and as a marker antigen for Ewing’s tumours [see 40]. CD99 is expressed on many tissues including red cells. By somatic cell hybridization and biochemical studies, Goodfellow and his colleagues have shown that MIC2, the structural locus encoding the 12E7 antigen, is located on the short arm of the X chromosome and on the short arm of the Y chromosome within the pairing regions [43]. MIC2 has been cloned [44]. XG is X-borne. On red cells, CD99 expression is a quantitative polymorphism [45]. Family studies proved that this polymorphism is also caused by regulator genes on X and Y chromosomes. XG appears to be the regulator on the X [46]. There is variation in CD99 expression on cells other than red cells. In a recent publication, CD99 was found on all haemopoeitic cells but was variably expressed during leucocyte differentiation [40]. Use of different monoclonal antibodies and variability of expression during maturation offered an explanation for the previous apparently contradictory findings by different laboratories. Both Xga and CD99 are sialoglycoproteins [47,48,49]. These glycoproteins differ in Mr and in their sialic acid content [49]. Immunostaining of separated membrane components with 12E7 and similar antibodies had demonstated that the MIC2 gene product was a 30-32 kD protein. 12E7 also bound to an intracellular band of 28 kD which was found in mouse cell lines in addition to human cell lines, platelets, lymphocytes and red cells but it was not encoded by the MIC2 gene [47]. Immunoblotting assays have shown that Xga was associated with two diffuse bands of 22-25 kD and 26.5-29 kD [49]. These findings supported the evidence that Xga and CD99 were products of different structural loci. However, XG appears to regulate CD99 expression on red cells and Latron and colleagues found that purified CD99 protein inhibited binding of 12E7 and of anti-Xga to red cells [48]. We have studied the immunochemical relationship of Xga and CD99 [50]. One approach was immunoprecipitation of membrane components from biotin labelled cells. Bands are detected by chemiluminescence via peroxidase-conjugated avidin. The 32 kD protein of CD99 was visualised by this technique and the quantitative polymorphism was also demonstrated since the 32 kD band is seen on X-ray film after 2 minutes in membranes." In Transfusion Immunology and Medicine, 197. CRC Press, 1995. http://dx.doi.org/10.1201/9781482273441-15.
Full textConference papers on the topic "SET-2 cell lines"
Inufusa, H., N. Sagara, K. Nakano, and M. Yasutomi. "CHARACTERISATION OF PLATELET AGGREGATING MATERIAL EXTRACTED FROM HUMAN LUNG ADENOCARCINOMA CELL LINE WHICH METASTASIZED IN NUDE MICE S,C, IMPLANTATION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643199.
Full textRodrigues, Júlia Morales, and Camila Biberg. "SIGNIFICADO CLÍNICO DE “HARLEQUIN CELL” NA SÍNDROME HIPEREOSINOFÍLICA PRIMARIA: ESTUDO DE REVISÃO." In II Congresso Brasileiro de Saúde On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/1513.
Full textDunkers, Joy P., Stefan D. Leigh, Marcus T. Cicerone, Forrest A. Landis, Francis W. Wang, and John A. Tesk. "NIST Development of Reference Material Scaffolds for Tissue Engineering." In ASME 2005 International Mechanical Engineering Congress and Exposition. ASMEDC, 2005. http://dx.doi.org/10.1115/imece2005-82012.
Full textAy, Emrah, and Nizami Duran. "Resistance of SARS CoV-2 to Seawater." In The 9th International Conference on Advanced Materials and Systems. INCDTP - Leather and Footwear Research Institute (ICPI), Bucharest, Romania, 2022. http://dx.doi.org/10.24264/icams-2022.iii.2.
Full textBonotto, Nathália Cardoso De Afonso, Bárbara Osmarin Turra, Cibele Ferreira Teixeira, Ivana Beatrice Mânica Cruz, and Fernanda Barbisan. "QUETIAPINA NÃO-METABOLIZADA MODULA A FORMAÇÃO DE ARMADILHAS EXTRACELULARES DE NEUTRÓFILOS." In I Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/997.
Full textPereira, Júlia de Paula, FABIANA MARIA OLIVEIRA BAÊTA, JOÃO VITOR FREITAS LANZA AVELAR, NILCIANY APARECIDA DE SOUSA RIBEIRO, and ALVARO FERNANDO SILVA NASCIMENTO. "O PAPEL DAS CÉLULAS NKS NA RESPOSTA IMUNOLÓGICA CONTRA O VÍRUS SARS-COV-2." In II Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conbrai/6038.
Full textTrinnye, Luizze Santos, Bruna Carolina Rangel Fortes, Caroline Domingues Zwicker, and Gabriele Soares Martins. "IMPLICAÇÕES FISIOPATOLÓGICAS DO COVID-19 NA ANEMIA FALCIFORME: UMA REVISÃO BIBLIOGRÁFICA." In I Congresso Brasileiro de Hematologia Clínico-laboratorial On-line. Revista Multidisciplinar em Saúde, 2021. http://dx.doi.org/10.51161/rems/617.
Full textSundararajan, Desikan, and Abdul-Majeed Azad. "Development of Logistic Fuel Desulfurizers Endowed With Nanoartifacts." In ASME 2008 6th International Conference on Fuel Cell Science, Engineering and Technology. ASMEDC, 2008. http://dx.doi.org/10.1115/fuelcell2008-65138.
Full textZhang, Qingwei, Ioannis Neitzel, Vadym N. Mochalin, Isabel Knoke, David M. Wootton, Yury Gogotsi, Peter I. Lelkes, and Jack G. Zhou. "PLLA-Nanodiamond Composites and Their Application in Bone Tissue Engineering." In ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology. ASMEDC, 2010. http://dx.doi.org/10.1115/nemb2010-13336.
Full textSidarta, Djoni E., Nicolas Tcherniguin, Philippe Bouchard, and Ho-Joon Lim. "Sensitivity Analysis of an ANN-Based System for Detection of Mooring Line Failure." In ASME 2020 39th International Conference on Ocean, Offshore and Arctic Engineering. American Society of Mechanical Engineers, 2020. http://dx.doi.org/10.1115/omae2020-18818.
Full textReports on the topic "SET-2 cell lines"
Ohad, Nir, and Robert Fischer. Regulation of Fertilization-Independent Endosperm Development by Polycomb Proteins. United States Department of Agriculture, January 2004. http://dx.doi.org/10.32747/2004.7695869.bard.
Full textTucker, Mark L., Shimon Meir, Amnon Lers, Sonia Philosoph-Hadas, and Cai-Zhong Jiang. Elucidation of signaling pathways that regulate ethylene-induced leaf and flower abscission of agriculturally important plants. United States Department of Agriculture, January 2012. http://dx.doi.org/10.32747/2012.7597929.bard.
Full textChejanovsky, Nor, and Bruce A. Webb. Potentiation of pest control by insect immunosuppression. United States Department of Agriculture, July 2004. http://dx.doi.org/10.32747/2004.7587236.bard.
Full textBlum, Abraham, Henry T. Nguyen, and N. Y. Klueva. The Genetics of Heat Shock Proteins in Wheat in Relation to Heat Tolerance and Yield. United States Department of Agriculture, August 1993. http://dx.doi.org/10.32747/1993.7568105.bard.
Full textSessa, Guido, and Gregory Martin. A functional genomics approach to dissect resistance of tomato to bacterial spot disease. United States Department of Agriculture, January 2004. http://dx.doi.org/10.32747/2004.7695876.bard.
Full textFunkenstein, Bruria, and Shaojun (Jim) Du. Interactions Between the GH-IGF axis and Myostatin in Regulating Muscle Growth in Sparus aurata. United States Department of Agriculture, March 2009. http://dx.doi.org/10.32747/2009.7696530.bard.
Full textHorwitz, Benjamin, and Nicole M. Donofrio. Identifying unique and overlapping roles of reactive oxygen species in rice blast and Southern corn leaf blight. United States Department of Agriculture, January 2017. http://dx.doi.org/10.32747/2017.7604290.bard.
Full textFluhr, Robert, and Maor Bar-Peled. Novel Lectin Controls Wound-responses in Arabidopsis. United States Department of Agriculture, January 2012. http://dx.doi.org/10.32747/2012.7697123.bard.
Full textSherman, Amir, Rebecca Grumet, Ron Ophir, Nurit Katzir, and Yiqun Weng. Whole genome approach for genetic analysis in cucumber: Fruit size as a test case. United States Department of Agriculture, December 2013. http://dx.doi.org/10.32747/2013.7594399.bard.
Full textFunkenstein, Bruria, and Cunming Duan. GH-IGF Axis in Sparus aurata: Possible Applications to Genetic Selection. United States Department of Agriculture, November 2000. http://dx.doi.org/10.32747/2000.7580665.bard.
Full text